CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 146 filers reported holding CLOVIS ONCOLOGY INC in Q4 2014. The put-call ratio across all filers is 0.43 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $370,000 | +138.7% | 310,123 | +259.6% | 0.00% | – |
| Q2 2022 | $155,000 | -37.8% | 86,243 | +35.9% | 0.00% | -100.0% |
| Q3 2019 | $249,000 | -61.7% | 63,476 | +75.4% | 0.00% | -71.4% |
| Q4 2018 | $650,000 | -23.2% | 36,184 | +25.7% | 0.01% | +75.0% |
| Q3 2018 | $846,000 | -44.4% | 28,794 | +55.1% | 0.00% | -94.4% |
| Q3 2017 | $1,522,000 | +163.8% | 18,567 | +202.3% | 0.07% | +184.0% |
| Q2 2017 | $577,000 | -84.4% | 6,141 | -92.6% | 0.02% | +4.2% |
| Q4 2016 | $3,687,000 | -38.3% | 83,014 | -49.9% | 0.02% | -42.9% |
| Q3 2016 | $5,975,000 | +691.4% | 165,737 | +1919.2% | 0.04% | +366.7% |
| Q3 2015 | $755,000 | +257.8% | 8,208 | +76.8% | 0.01% | +200.0% |
| Q3 2014 | $211,000 | – | 4,642 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 814,833 | $60,485,054,000 | 53.20% |
| Palo Alto Investors LP | 2,121,857 | $157,505,000 | 7.79% |
| NEA Management Company, LLC | 2,279,781 | $169,228,000 | 7.65% |
| EcoR1 Capital, LLC | 243,048 | $18,041,000 | 6.01% |
| Redmile Group, LLC | 900,879 | $66,872,000 | 6.00% |
| Opaleye Management Inc. | 140,000 | $10,392,000 | 4.82% |
| PFM Health Sciences, LP | 2,266,756 | $168,261,000 | 4.64% |
| Partner Investment Management, L.P. | 40,798 | $3,028,000 | 4.56% |
| CLIFTON PARK CAPITAL MANAGEMENT, LLC | 826,919 | $61,383,000 | 3.74% |
| Opus Point Partners Management, LLC | 55,988 | $4,156,000 | 3.48% |